International Journal of Advanced and Integrated Medical Sciences

Register      Login

VOLUME 2 , ISSUE 3 ( July-September, 2017 ) > List of Articles

ORIGINAL ARTICLE

Intravenous Dexmedetomidine enhances the Duration of Spinal Anesthesia with 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries

Malti Agrawal, Yogesh K Sharma

Citation Information : Agrawal M, Sharma YK. Intravenous Dexmedetomidine enhances the Duration of Spinal Anesthesia with 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries. Int J Adv Integ Med Sci 2017; 2 (3):144-148.

DOI: 10.5005/jp-journals-10050-10094

License: CC BY 3.0

Published Online: 01-12-2017

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

Introduction

Spinal block is a preferred technique for most lower abdominal and lower limb surgeries. Lignocaine had been the local anesthetic of choice for decades in such surgeries. With the advent of adjuvants, now it has become possible to enhance the duration of spinal anesthesia. These adjuvants can be given intravenously or intrathecally. Intravenous clonidine and dexmedetomidine have been used in recent studies as adjuvant in spinal anesthesia with promising results. Dexmedetomidine is a more suitable adjuvant compared with clonidine due to its more selective alpha-2A receptor agonist activity.

Aims and objectives

To evaluate the effect of intravenous dexmedetomidine on spinal anesthesia with 0.5% bupivacaine in lower abdominal surgeries in terms of onset and duration of sensory and motor blockade and sensory regression.

Materials and methods

Sixty patients of American Society of Anesthesiologists grades I and II, 25 to 60 years of age, posted for elective lower abdominal surgeries under spinal anesthesia were included in the study and randomly allocated into computer-generated two groups. Group IV received intrathecal 0.5% bupivacaine heavy and intravenous infusion of dexmedetomidine 1 μg/kg over 20 minutes followed by 0.5 μg/kg/hour till the end of surgery. Patients in group III (control group) received intrathecal 0.5% bupivacaine heavy and intravenous normal saline as placebo.

Results

In groups IV and III, mean duration of analgesia was 209 ± 29.93 and 150.20 ± 3.46 minutes respectively. This increase in duration of analgesia in dexmedetomidine group was statistically significant. The mean duration of motor blockade was 189.48 ± 1.34 and 158.18 ± 3.27 minutes respectively. Injection diclofenac sodium 75 mg intramuscularly was used as rescue analgesic.

How to cite this article

Sharma YK, Agrawal M. Intravenous Dexmedetomidine enhances the Duration of Spinal Anesthesia with 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries. Int J Adv Integ Med Sci 2017;2(3):144-148.


HTML PDF Share
  1. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand 2006 Feb;50(2):222-227.
  2. Intravenous dexmedetomidine prolongs bupivacaine spinal analgesia. Middle East J Anaesthesiol 2009 Jun;20(2):225-231.
  3. Clinical uses of alpha2-adrenergic agonists. Anaesthesiology 2000 Nov;93(5):1345-1349.
  4. Low dose intrathecal clonidine with bupivacaine improves onset and duration of block with hemodynamic stability. Internet J Anaesthesiol 2009;23(1).
  5. Intrathecal clonidine as an adjuvant to hyperbaric bupivacaine in patients undergoing inguinal herniorrhaphy: a randomized double-blinded study. J Anaesthesiol Clin Pharmacol 2013 Jan;29(1):66-70.
  6. Efficacy of analgesic effects of low dose intrathecal clonidine as adjuvant to bupivacaine. Indian J Anaesth 2007;51(5):415-419.
  7. Effect of dexmedetomidine IV on the duration of spinal anaesthesia with prilocaine: a double blind, prospective study in adult surgical patients. Curr Ther Res Clin Exp 2007 Sep;68(5):313-324.
  8. Comparison of dexmedetomidine and three different doses of midazolamin preoperative sedation. J Anaesthesiol Clin Pharmacol 2011 Jul;27(3):367-372.
  9. Prolongation of subarachnoid block by intravenous dexmedetomidine for sub umbilical surgical procedures: a prospective control study. Anaesth Essays Res 2014 May-Aug;8(2):175-178.
  10. Intravenous dexmedetomidine vs. intravenous clonidine to prolong bupivacaine spinal anaesthesia. A double blind study. Anestesia en Mexico 2007;19:143-146.
  11. Perioperative uses of dexmedetomidine. Middle East J Anaesthesiol 2006 Oct;18(6):1043-1058.
  12. A crucial review of visual analogue scales in the measurement of clinical phenomenon. Res Nurs Health 1990 Aug;13(4):227-236.
  13. Dexmedetomidine: new avenues. J Anaesthesiol Clin Pharmacol 2011 Jul;27(3):293-302.
  14. Local anaesthetics: l. N-alkyl pyrrolidine and N-alkyl piperidine carboxylic amides. Acta Chem Scand 1957;11:1183-1190.
  15. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000;4(5):302-308.
  16. Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions. Anaesth Analg 2000 Mar;90(3):699-705.
  17. A technique to reduce incidence of headache following lumbar puncture in ambulatory patients with a plea for more frequent examination of cerebral fluid. Northwest Med 1923;22:240-245.
  18. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent) 2001 Jan;14(1):13-21.
  19. Intravenous dexmedetomidine, but not midazolam, prolongs bupivacaine spinal anaesthesia. Can J Anaesth 2010 Jan;57(1):39-45.
  20. Intravenous dexmedetomidine or propofol adjuvant to spinal anaesthesia in total knee replacement surgery. J Med J 2011 Sep;45(2):174-183.
  21. The effects of intravenous dexmedetomidine on spinal hyperbaric ropivacaine anaesthesia. J Jpn Soc Anaesthesiol 2010 Aug;24(4):544-548.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.